What it is and how it works
From the published literature on IGF-1 DES; the papers are listed at the end. Research summary, not a recommendation.
What it is
IGF-1 DES (des(1-3)IGF-I) is a shortened natural form of insulin-like growth factor 1 (IGF-1, a hormone that drives growth and tissue building) that lacks the first three amino acids (Gly-Pro-Glu) at one end. It has been isolated from bovine colostrum, human brain and pig uterus, and probably forms when IGF-1 is clipped after it is made. Research is limited to cell and animal studies; a 1996 review noted that clinical uses had not yet been evaluated, and no human trial was found in PubMed as of 2026-11-06.
How it works
Most IGF-1 in the blood is held by IGF-binding proteins, which limit how much can reach cells. Losing the three amino acids, and especially the glutamate at position 3, sharply reduces binding to those proteins, so des(1-3)IGF-I is generally about ten times more potent than IGF-1 at stimulating cell growth in culture. In rats and mice that extra potency partly carried over, with anabolic (tissue-building) effects in the gut, kidney and heart, and in diabetic rats it improved nitrogen retention and muscle protein synthesis.
What it has been studied for
- Growth of cultured cells and its escape from IGF-binding proteins (laboratory studies)
- Body and organ growth in dwarf (lit/lit) mice (animal study)
- Weight gain and muscle protein synthesis in diabetic rats (animal study)
- Possible use in catabolic (tissue-wasting) states, flagged as unevaluated (review)
Strength of the evidence
Animal and lab studiesThe data are cell and rodent studies from the 1980s and 1990s; no human trial of this form was found.
What the literature reports on safety
No safety data in people were found. Its parent hormone, IGF-1, is an FDA-approved medicine (mecasermin, initial US approval 2005) for a specific growth disorder, and its label warns of low blood sugar and cancer risk, cautions that cannot be assumed to be identical for the truncated form. Published copies of the 2026 WADA Prohibited List name IGF-1 and its analogues among prohibited growth factors (section S2). IGF-1 DES is not named on the FDA compounding-substances page (content current as of 2026-04-22).
Key papers
Des(1-3)IGF-I: a truncated form of insulin-like growth factor-I. (opens in a new tab)
Review · Ballard FJ, Wallace JC, et al. · International Journal of Biochemistry & Cell Biology (1996) · PMID 8930132
Reviewed this IGF-1 variant as about ten-fold more potent in cultured cells because it binds IGF-binding proteins far less, with clinical uses not yet evaluated.
Lab (in vitro) · Ross M, Francis GL, et al. · Biochemical Journal (1989) · PMID 2539101
A binding protein from kidney cells blocked IGF-2 and partly IGF-1 in chick fibroblasts but did not affect des-(1-3)-IGF-1.
Lab (in vitro) · Lindgren BF, Isaksson M, et al. · Acta Endocrinologica (1993) · PMID 7680515
Des-(1-3) IGF-I lowered IGFBP-1 levels in liver-cell culture medium dose-dependently, showing it acts on the binding-protein system.
Animal study · Gillespie C, Read LC, et al. · Journal of Endocrinology (1990) · PMID 2280209
In lit/lit mice (a strain with low growth hormone), the lower dose of the truncated form, but not of IGF-1, raised kidney and heart weights, so the higher potency seen in cells also held in animals.
Animal study · Tomas FM, Knowles SE, et al. · Biochemical Journal (1991) · PMID 1710892
In diabetic rats, des(1-3)IGF-I produced about 70% of insulin's improvement in weight gain and nitrogen retention, more than IGF-1 at the same dose.
Sources checked: PubMed (E-utilities abstracts for every PMID), FDA compounding-substances page (current as of 2026-04-22), published copies of the WADA 2026 Prohibited List (via search; official PDF text not machine-readable), written 2026-11-06.
No sources yet
None of the three teachers' sources we have indexed discuss IGF-1 DES yet. This page will fill in as sources are added.
Deeper guided audio lives on What Am I Appreciating Now (leaves this site, opens in a new tab). What Am I Appreciating Now is a separate site run by the same operator; it sells meditation and hypnosis sessions.
Disclaimer: for research purposes only
All content on this page is for research and educational purposes only and is not intended as medical advice. Always consult a qualified healthcare provider before starting any peptide or hormone protocol. You take responsibility for your own protocol.If your path includes peptides, you buy them yourself from an independent licensed provider through a member co-op; we take nothing. How independent access works.